MATTERHORN: Efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer-A randomized, double-blind, placebo-controlled, phase 3 study.

被引:21
|
作者
Janjigian, Yelena Y.
Van Cutsem, Eric
Muro, Kei
Wainberg, Zev A.
Al-Batran, Salah-Eddin
Hyung, Woo Jin
Molena, Daniela
Evans, Brent
Ruscica, Dario
Robbins, Scott H.
Negro, Alejandra
Tabernero, Josep
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Univ Hosp Gasthuisberg, Leuven, Belgium
[3] KU Leuven, Leuven, Belgium
[4] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[5] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA USA
[6] Univ Canc Ctr, Frankfurt, Germany
[7] Univ Coll Med, Seoul, South Korea
[8] AstraZeneca, Gaithersburg, MD USA
[9] UVic UCC, Vall dHebron Univ Hosp & Vall dHebron Inst Oncol, Barcelona, Spain
关键词
D O I
10.1200/JCO.2021.39.15_suppl.TPS4151
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS4151
引用
收藏
页数:3
相关论文
共 50 条
  • [21] A randomized double-blind placebo-controlled phase 2 study on the efficacy and safety of fasudil in patients with stable angina
    Vicari, RM
    Chaitman, B
    Keefe, D
    Smith, WB
    Chrysant, ST
    Tonkon, MJ
    Bittar, N
    Weiss, RJ
    Thadani, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 254A - 254A
  • [22] A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis
    Guntupalli, Kalpalatha
    Dean, Nathan
    Morris, Peter E.
    Bandi, Venkata
    Margolis, Benjamin
    Rivers, Emanuel
    Levy, Mitchell
    Lodato, Robert F.
    Ismail, Preeti M.
    Reese, Amber
    Schaumberg, John P.
    Malik, Rajesh
    Dellinger, R. Phillip
    CRITICAL CARE MEDICINE, 2013, 41 (03) : 706 - 716
  • [23] Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study
    Earley, Willie R.
    Burgess, Maria V.
    Khan, Barbara
    Rekeda, Ludmyla
    Suppes, Trisha
    Tohen, Mauricio
    Calabrese, Joseph R.
    BIPOLAR DISORDERS, 2020, 22 (04) : 372 - 384
  • [24] Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double-blind, placebo-controlled, Phase 2 study
    King, B.
    Mesinkovska, N.
    Senna, M.
    Luo, X.
    Minkiewicz, J.
    Selfridge, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025,
  • [25] Efficacy of etanercept (Enbrel®) in the treatment of ankylosing spondylitis:: A randomized, placebo-controlled, double-blind study.
    Gorman, JD
    Sack, KE
    Davis, JC
    ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2947 - 2947
  • [26] Efficacy and Safety of AMG 853 in Asthma: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Busse, W. W.
    Wenzel, S. E.
    Meltzer, E. O.
    Kerwin, E. M.
    Liu, M. C.
    Zhang, N.
    Chon, Y.
    Lin, J.
    Lin, S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB202 - AB202
  • [27] Antiemetic efficacy of ondansetron in laparoscopic cholecystectomy.: A randomized, double-blind, placebo-controlled study.
    de Adana, JCR
    Bonis, RT
    Galán, FG
    Matías, AH
    Luengas, DF
    Deballón, PO
    Herrero, JL
    Azcoita, MM
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1999, 91 (09) : 639 - 641
  • [28] Pembrolizumab plus FLOT vs FLOT as neoadjuvant and adjuvant therapy in locally advanced gastric and gastroesophageal junction cancer: Interim analysis of the phase 3 KEYNOTE-585 study.
    Al-Batran, Salah-Eddin
    Shitara, Kohei
    Folprecht, Gunnar
    Moehler, Markus H.
    Goekkurt, Eray
    Ben-Aharon, Irit
    Lonardi, Sara
    Stein, Stacey
    Hubert, Ayala
    Chau, Ian
    Mishaeli, Moshe
    Villanueva, Luis
    Kavan, Petr
    Fang, Xiao
    Shih, Chie-Schin
    Bhagia, Pooja
    Wyrwicz, Lucjan S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 247 - 247
  • [29] Safety and efficacy of ataluren in nmDMD patients from Study 041, a phase 3, randomized, double-blind, placebo-controlled trial
    McDonald, C.
    Wu, S.
    Gulati, S.
    Komaki, H.
    Ruiz-Garcia, M.
    Kostera-Pruszczyk, A.
    Vlodavets, D.
    Chae, J.
    Jong, Y.
    Karachunski, P.
    Statland, J.
    Lorentzos, M.
    Penematsa, V
    Chou, C.
    Lin, M.
    Werner, C.
    Trifillis, P.
    Gordon, G.
    Klein, M.
    NEUROMUSCULAR DISORDERS, 2022, 32
  • [30] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V.
    Goadsby, P. J.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 28 - 29